0001835856 false 0001835856 2023-03-26 2023-03-26 0001835856 AURCU:UnitsEachConsistingOfOneShareOfClassOrdinaryShareAndOnequarterOfOneRedeemableWarrantMember 2023-03-26 2023-03-26 0001835856 AURCU:ClassOrdinaryShareParValue0.0001PerShareMember 2023-03-26 2023-03-26 0001835856 AURCU:RedeemableWarrantsIncludedAsPartOfUnitsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member 2023-03-26 2023-03-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 26, 2023

 

 

 

AURORA ACQUISITION CORP. 

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands 001-40143 98-1628701
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation or organization) File Number) Identification No.)

 

20 North Audly Street  
London W1K 6LX  
United Kingdom
(Address of principal executive offices) (Zip Code)

 

+44 (0)20 3931 9785

Registrant’s telephone number, including area code

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s)

Name of each exchange on
which
registered 

Units, each consisting of one share of Class A ordinary share and one-quarter of one redeemable warrant AURCU The Nasdaq Stock Market LLC
Class A ordinary share, par value $0.0001 per share AURC The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AURCW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 4.02(a). Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

In connection with the preparation of the financial statements of Aurora Acquisition Corp. (the “Company”) for the year ended December 31, 2022, the Company’s management and its advisors determined that certain errors relating to expenses were not properly recorded in the period in which they occurred. After further review and taking into consideration the amounts of the expenses and that they included a related-party transaction, on March 26, 2023, the Audit Committee (the “Audit Committee”) of the board of directors of the Company (the “Board”) and the Board, in consultation with the Company’s management and its advisors, concluded that the Company’s previously issued financial statements issued in connection with: (i) the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, originally filed on March 25, 2022 (the “2021 Form 10-K”); and (ii) the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended September 30, 2021, March 31, 2022, June 30, 2022 and September 30, 2022, originally filed on November 15, 2021, May 16, 2022, August 15, 2022 and November 14, 2022, respectively (collectively, the “Affected Periods”) should no longer be relied upon. As such, the Company intends to restate its financial statements for the Affected Periods in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”), which the Company will file with the SEC as soon as practicable.

 

The Company does not expect any of the above changes will have any impact on its cash position and cash held in the trust account established in connection with the Company’s initial public offering.

 

The Company’s management has concluded that, in light of the errors described above, a material weakness exists in the Company’s internal control over financial reporting for the Affected Periods. The Company’s remediation plan with respect to such material weakness will be described in more detail in the 2022 Form 10-K.

 

The Company’s management and the Audit Committee have discussed the matters disclosed in this Current Report on Form 8-K pursuant to this Item 4.02(a) with Marcum LLP, the Company’s independent registered public accounting firm.

 

 

 

 

Cautionary Statement Regarding Forward-Looking Information

 

This current report on Form 8-K contains “forward-looking statements.” Statements that constitute projections, forecasts and other forward-looking statements are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. Such statements are subject to certain risks and uncertainties, which could cause the Company’s actual results to differ materially from those anticipated by the forward-looking statements. These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the Company’s filings with the Securities and Exchange Commission. Actual results (including, without limitation the timing for and results of the Company’s pending restatements) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 29, 2023

 

  By:

/s/ Arnaud Massenet

  Name: Arnaud Massenet
  Title: Chief Executive Officer